对“miR-641表达增加通过靶向NF1促进非小细胞肺癌细胞对厄洛替尼的耐药”的更正

IF 3.1 2区医学 Q2 ONCOLOGY

Cancer Medicine Pub Date : 2025-05-19 DOI:10.1002/cam4.70967

引用次数: 0

摘要

陈健，崔建东，郭晓涛，曹旭，李强。“miR-641表达增加通过靶向NF - 1参与非小细胞肺癌细胞厄洛替尼耐药。”《癌症医学》2018；7:1394 - 1403。https://doi.org/10.1002/cam4.1326.We为这个错误道歉。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Correction to “Increased Expression of miR-641 Contributes to Erlotinib Resistance in Non-Small-Cell Lung Cancer Cells by Targeting NF1”

查看原文本刊更多论文

Correction to “Increased Expression of miR-641 Contributes to Erlotinib Resistance in Non-Small-Cell Lung Cancer Cells by Targeting NF1”

Chen J, Cui J-d, Guo X-t, Cao X, Li Q. “Increased expression of miR-641 contributes to erlotinib resistance in non-small-cell lung cancer cells by targeting NF 1.” Cancer Med. 2018; 7:1394–1403. https://doi.org/10.1002/cam4.1326.

We apologize for this error.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cancer Medicine ONCOLOGY-

CiteScore

5.50

自引率

2.50%

发文量

907

审稿时长

19 weeks

期刊介绍： Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas: Clinical Cancer Research Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations Cancer Biology: Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery. Cancer Prevention: Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach. Bioinformatics: Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers. Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.